146 related articles for article (PubMed ID: 10469310)
1. Expression and role of IL-15 in post-burn hypertrophic scars.
Castagnoli C; Trombotto C; Ariotti S; Millesimo M; Ravarino D; Magliacani G; Ponzi AN; Stella M; Teich-Alasia S; Novelli F; Musso T
J Invest Dermatol; 1999 Aug; 113(2):238-45. PubMed ID: 10469310
[TBL] [Abstract][Full Text] [Related]
2. Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin.
Fumagalli M; Musso T; Vermi W; Scutera S; Daniele R; Alotto D; Cambieri I; Ostorero A; Gentili F; Caposio P; Zucca M; Sozzani S; Stella M; Castagnoli C
Exp Dermatol; 2007 Jul; 16(7):600-10. PubMed ID: 17576240
[TBL] [Abstract][Full Text] [Related]
3. Characterization of T-cell subsets infiltrating post-burn hypertrophic scar tissues.
Castagnoli C; Trombotto C; Ondei S; Stella M; Calcagni M; Magliacani G; Alasia ST
Burns; 1997; 23(7-8):565-72. PubMed ID: 9568325
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of T lymphocytes infiltrating the dermis and epidermis of post-burn hypertrophic scar tissues.
Bernabei P; Rigamonti L; Ariotti S; Stella M; Castagnoli C; Novelli F
Burns; 1999 Feb; 25(1):43-8. PubMed ID: 10090383
[TBL] [Abstract][Full Text] [Related]
5. Post-burn hypertrophic scars are characterized by high levels of IL-1β mRNA and protein and TNF-α type I receptors.
Salgado RM; Alcántara L; Mendoza-Rodríguez CA; Cerbón M; Hidalgo-González C; Mercadillo P; Moreno LM; Alvarez-Jiménez R; Krötzsch E
Burns; 2012 Aug; 38(5):668-76. PubMed ID: 22226222
[TBL] [Abstract][Full Text] [Related]
6. Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury.
Tredget EE; Yang L; Delehanty M; Shankowsky H; Scott PG
J Interferon Cytokine Res; 2006 Mar; 26(3):179-89. PubMed ID: 16542140
[TBL] [Abstract][Full Text] [Related]
7. Keratinocyte-derived growth factors play a role in the formation of hypertrophic scars.
Niessen FB; Andriessen MP; Schalkwijk J; Visser L; Timens W
J Pathol; 2001 Jun; 194(2):207-16. PubMed ID: 11400150
[TBL] [Abstract][Full Text] [Related]
8. Activated keratinocytes in the epidermis of hypertrophic scars.
Machesney M; Tidman N; Waseem A; Kirby L; Leigh I
Am J Pathol; 1998 May; 152(5):1133-41. PubMed ID: 9588880
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiles from hypertrophic scar fibroblasts before and after IL-6 stimulation.
Dasu MR; Hawkins HK; Barrow RE; Xue H; Herndon DN
J Pathol; 2004 Apr; 202(4):476-85. PubMed ID: 15095275
[TBL] [Abstract][Full Text] [Related]
10. Epidermal participation in post-burn hypertrophic scar development.
Hakvoort TE; Altun V; Ramrattan RS; van der Kwast TH; Benner R; van Zuijlen PP; Vloemans AF; Prens EP
Virchows Arch; 1999 Mar; 434(3):221-6. PubMed ID: 10190301
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
[TBL] [Abstract][Full Text] [Related]
12. Lapachol suppresses cell proliferation and secretion of interleukin-6 and plasminogen activator inhibitor-1 of fibroblasts derived from hypertrophic scars.
Matsui T; Ito C; Oda M; Itoigawa M; Yokoo K; Okada T; Furukawa H
J Pharm Pharmacol; 2011 Jul; 63(7):960-6. PubMed ID: 21635262
[TBL] [Abstract][Full Text] [Related]
13. Dracorhodin perchlorate induces apoptosis in primary fibroblasts from human skin hypertrophic scars via participation of caspase-3.
Zhang P; Li J; Tang X; Zhang J; Liang J; Zeng G
Eur J Pharmacol; 2014 Apr; 728():82-92. PubMed ID: 24525335
[TBL] [Abstract][Full Text] [Related]
14. Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2.
Zaunders JJ; Moutouh-de Parseval L; Kitada S; Reed JC; Rought S; Genini D; Leoni L; Kelleher A; Cooper DA; Smith DE; Grey P; Estaquier J; Little S; Richman DD; Corbeil J
J Infect Dis; 2003 Jun; 187(11):1735-47. PubMed ID: 12751031
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic scarring is associated with epidermal abnormalities: an immunohistochemical study.
Andriessen MP; Niessen FB; Van de Kerkhof PC; Schalkwijk J
J Pathol; 1998 Oct; 186(2):192-200. PubMed ID: 9924436
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression.
Naora H; Gougeon ML
Cell Death Differ; 1999 Oct; 6(10):1002-11. PubMed ID: 10556978
[TBL] [Abstract][Full Text] [Related]
17. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics.
Polo M; Smith PD; Kim YJ; Wang X; Ko F; Robson MC
Ann Plast Surg; 1999 Aug; 43(2):185-90. PubMed ID: 10454327
[TBL] [Abstract][Full Text] [Related]
18. Hypertrophic scar formation is associated with an increased number of epidermal Langerhans cells.
Niessen FB; Schalkwijk J; Vos H; Timens W
J Pathol; 2004 Jan; 202(1):121-9. PubMed ID: 14694529
[TBL] [Abstract][Full Text] [Related]
19. Increased epidermal thickness and abnormal epidermal differentiation in keloid scars.
Limandjaja GC; van den Broek LJ; Waaijman T; van Veen HA; Everts V; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
Br J Dermatol; 2017 Jan; 176(1):116-126. PubMed ID: 27377288
[TBL] [Abstract][Full Text] [Related]
20. Expression and localization of insulin-like growth factor-1 in normal and post-burn hypertrophic scar tissue in human.
Ghahary A; Shen YJ; Wang R; Scott PG; Tredget EE
Mol Cell Biochem; 1998 Jun; 183(1-2):1-9. PubMed ID: 9655173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
